TrivarX Limited

Research TrivarX Limited (TRI.AX) on Bullrun: market cap AUD 10.38M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is AUD 10.38M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2024n/a-AUD 1.24M-AUD 3.70Mn/a0AUD 848.10KAUD 15.90KAUD 9.88M
FY2023AUD 22.07K-AUD 3.12M-AUD 3.19M99.3%-0.02AUD 214.11KAUD 103.70KAUD 6.30M
FY2022AUD 40.04K-AUD 12.72M-AUD 4.63M97.3%-0.12AUD 1.03MAUD 66.42KAUD 7.11M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-17AUD 10.38Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 AUD.

About TrivarX Limited

TrivarX Limited, a biotechnology company, engages in the development of AI-driven, and scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. It is also involved in research, development, and commercialisation of diagnostic and pharmaceutical products. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Hawthorn East, Australia.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is TrivarX Limited's market cap?

TrivarX Limited's market capitalization is AUD 10.38M.

What does TrivarX Limited do?

TrivarX Limited, a biotechnology company, engages in the development of AI-driven, and scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. It is also involved in research, development, and commercialisation of diagnostic and pharmaceutical products. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Hawthorn East, Australia.